Home » Headlines » Currently Reading:

Morning Headlines 5/17/17

May 16, 2017 Headlines No Comments

Inside Corey Lewandowski’s Failed Romp in Trump’s Swamp

GQ profiles Corey Lewandowski, a one time Trump campaign adviser that launched his own lobby firm after the election, offering access to Trump and influence across government agencies. Health IT vendor Flow Health hired the lobby firm to reverse a decision by the VA to cancel its contract, which it illegally agreed to pay $250,000 for if the decision was reversed.

State Rep. Rehder will file PDMP bill again next year; “I’m a fighter, and I know that we will get this done”

Missouri’s effort to pass prescription drug monitoring program legislation died  Friday afternoon after the Senate added a provision mandating use by providers, a clause the Missouri State Medical Association opposed. The bill then lost support and failed to pass by 6pm Friday, when the 2017 legislative session ended.

Google DeepMind’s use of 1.6m Brits’ medical records to test app was ‘legally inappropriate’

The National Data Guardian at the UK’s Department of Health states in a leaked memo that Google DeepMind’s use of real NHS medical records to test an app designed to diagnose kidney disease was legally "inappropriate.”

Bipartisan bill will be reintroduced to force pharma to justify price hike

A bipartisan group of Senators introduce the Fair Drug Pricing Act, a bill that would require that pharmaceutical companies submit a report to HHS before increasing the price of a drug by 10 percent in one year, or by 25 percent over three years.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links